FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ken Williams

Research Profile

Disorders

Geographic Areas

Texas
Mexico

Concepts & Ideas

Chemicals & Drugs

Living Beings

Mexican Americans

Procedures

Glucose Tolerance Test

Co-author Network

Publications

TOP 3
Gabriel E Burkhardt; Shaun M Gifford; Brandon Propper; Jerry R Spencer; Ken Williams; Lyell Jones; Nathan Sumner; Jerry Cowart; Todd E Rasmussen
The impact of ischemic intervals on neuromuscular recovery in a porcine (Sus scrofa) survival model of extremity vascular injury.
Gabriel E Burkhardt; Mitchell Cox; W Darrin Clouse; Chantel Porras; Shaun M Gifford; Ken Williams; Brandon W Propper; Todd E Rasmussen
Outcomes of selective tibial artery repair following combat-related extremity injury.
Carlos Lorenzo; Ken Williams; Michael P Stern; Steven M Haffner
Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ken Williams (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Gabriel E Burkhardt; Shaun M Gifford; Brandon Propper; Jerry R Spencer; Ken Williams; Lyell Jones; Nathan Sumner; Jerry Cowart; Todd E Rasmussen
The impact of ischemic intervals on neuromuscular recovery in a porcine (Sus scrofa) survival model of extremity vascular injury.
Journal of vascular surgery 2011;53(1):165-73.
2010: Gabriel E Burkhardt; Mitchell Cox; W Darrin Clouse; Chantel Porras; Shaun M Gifford; Ken Williams; Brandon W Propper; Todd E Rasmussen
Outcomes of selective tibial artery repair following combat-related extremity injury.
Journal of vascular surgery 2010;52(1):91-6.
2009: Carlos Lorenzo; Ken Williams; Michael P Stern; Steven M Haffner
Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study.
Metabolism: clinical and experimental 2009;58(11):1530-5.
2008: Sharon P Fowler; Ken Williams; Roy G Resendez; Kelly J Hunt; Helen Hazuda; Michael P Stern
Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain.
Obesity (Silver Spring, Md.) 2008;16(8):1894-900.
2008: Michael P Stern; Ken Williams; David Eddy; Richard Kahn
Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models.
Diabetes care 2008;31(8):1670-1.
2008: Andreas Festa; Ken Williams; Anthony J G Hanley; Steven M Haffner
Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Diabetes 2008;57(6):1638-44.
2007: Muhammad Abdul-Ghani; Ken Williams; Ralph DeFronzo; Michael P Stern
What is the best predictor of future type 2 diabetes?
Diabetes care 2007;30(6):1544-8.
2007: Carlos Lorenzo; Manuel Serrano-Ríos; María T Martínez Larrad; Clicerio Gonzalez-Villalpando; Ken Williams; Rafael Gabriel; Michael P Stern; Steven M Haffner
Which obesity index best explains prevalence differences in type 2 diabetes mellitus?
Obesity (Silver Spring, Md.) 2007;15(5):1294-301.
2007: Carlos Lorenzo; Ken Williams; Kelly J Hunt; Steven M Haffner
The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
Diabetes care 2007;30(1):8-13.
2006: Monica Nannipieri; Rosalinda Posadas-Sánchez; Alessandra Bonotti; Ken Williams; Clicerio Gonzalez-Villalpando; Michael P Stern; Ele Ferrannini
Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes: a population-based study.
Diabetes care 2006;29(11):2509-11.
2006: Muhammad Abdul-Ghani; Ken Williams; Ralph DeFronzo; Michael P Stern
Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
Diabetes care 2006;29(7):1613-8.
2006: Andreas Festa; Ken Williams; Russell P Tracy; Lynne E Wagenknecht; Steven M Haffner
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Circulation 2006;113(14):1753-9.
2006: Andreas Festa; Ken Williams; Ralph D'Agostino; Lynne E Wagenknecht; Steven M Haffner
The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.
Diabetes 2006;55(4):1114-20.
2006: Carlos Lorenzo; Manuel Serrano-Ríos; María T Martínez Larrad; José L González-Sánchez; Segundo Seclén; Arturo Villena; Clicerio Gonzalez-Villalpando; Ken Williams; Steven M Haffner
Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects.
Diabetes care 2006;29(3):685-91.
2006: Carlos Lorenzo; Ken Williams; Kelly J Hunt; Steven M Haffner
Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study.
Diabetes care 2006;29(3):625-30.
2005: Anthony J G Hanley; Andrew J Karter; Ken Williams; Andreas Festa; Ralph B D'Agostino; Lynne E Wagenknecht; Steven M Haffner
Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
Circulation 2005;112(24):3713-21.
2005: Anthony J G Hanley; Ken Williams; Andreas Festa; Lynne E Wagenknecht; Ralph B D'Agostino; Steven M Haffner
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
Diabetes 2005;54(11):3140-7.
2005: Carlos Lorenzo; Ken Williams; Clicerio Gonzalez-Villalpando; Steven M Haffner
The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity.
Diabetes care 2005;28(10):2480-5.
2005: Aida Jimenez Corona; David Rivera Martinez; Mauricio Hernandez Avila; Steven M Haffner; Ken Williams; Maria Elena González Villalpando; Jesus Simon; Michael P Stern; Clicerio Gonzalez-Villalpando
Microalbuminuria as a predictor of myocardial infarction in a Mexican population: the Mexico City Diabetes Study.
Kidney international. Supplement 2005;(97):S34-9.
2005: Monica Nannipieri; Clicerio Gonzales; Simona Baldi; Rosalinda Posadas-Sánchez; Ken Williams; Steven M Haffner; Michael P Stern; Ele Ferrannini
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.
Diabetes care 2005;28(7):1757-62.
2005: Andreas Festa; Ken Williams; Anthony J G Hanley; James D Otvos; David C Goff; Lynne E Wagenknecht; Steven M Haffner
Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
Circulation 2005;111(25):3465-72.
2005: Michael P Stern; Ken Williams; Kelly J Hunt
Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease.
Atherosclerosis. Supplements 2005;6(2):3-6.
2005: Carlos Lorenzo; Ken Williams; Clicerio Gonzalez-Villalpando; Michael P Stern; Helen Hazuda; Steven M Haffner
Lower hypertension risk in Mexico City than in San Antonio.
American journal of hypertension 2005;18(3):385-91.
2004: Michael P Stern; Ken Williams; Clicerio González-Villalpando; Kelly J Hunt; Steven M Haffner
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
Diabetes care 2004;27(11):2676-81.
2004: Anthony J G Hanley; Ken Williams; Andreas Festa; Lynne E Wagenknecht; Ralph B D'Agostino; Judy Kempf; Bernard Zinman; Steven M Haffner
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes 2004;53(10):2623-32.
2004: Kelly J Hunt; Roy G Resendez; Ken Williams; Steven M Haffner; Michael P Stern
National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
Circulation 2004;110(10):1251-7.
2004: Ken Williams; Michael P Stern; Clicerio Gonzalez-Villalpando
Secular trends in obesity in Mexico City and in San Antonio.
Nutrition reviews 2004;62(7 Pt 2):S158-62.
2004: James B Meigs; Ken Williams; Lisa M Sullivan; Kelly J Hunt; Steven M Haffner; Michael P Stern; Clicerio González-Villalpando; Jessica S Perhanidis; David M Nathan; Ralph B D'Agostino; Ralph B D'Agostino; Peter W F Wilson
Using metabolic syndrome traits for efficient detection of impaired glucose tolerance.
Diabetes care 2004;27(6):1417-26.
2004: Ele Ferrannini; Monica Nannipieri; Ken Williams; Clicerio Gonzales; Steve M Haffner; Michael P Stern
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance.
Diabetes 2004;53(1):160-5.
2003: Carlos Lorenzo; Manuel Serrano-Ríos; María T Martínez Larrad; Rafael Gabriel; Ken Williams; Juan A Gomez Gerique; Michael P Stern; Steven M Haffner
Central adiposity determines prevalence differences of the metabolic syndrome.
Obesity research 2003;11(12):1480-7.
2003: Kelly J Hunt; Roy G Resendez; Ken Williams; Steven M Haffner; Michael P Stern; Helen Hazuda
All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox".
American journal of epidemiology 2003;158(11):1048-57.
2003: Ken Williams; Allan D Sniderman; Naveed Sattar; Ralph D'Agostino; Lynne E Wagenknecht; Steven M Haffner
Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
Circulation 2003;108(19):2312-6.
2003: Carlos Lorenzo; Mayor Okoloise; Ken Williams; Michael P Stern; Steven M Haffner
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
Diabetes care 2003;26(11):3153-9.
2003: Kelly J Hunt; Ken Williams; David Rivera; Daniel H O'Leary; Steven M Haffner; Michael P Stern; Clicerio González-Villalpando
Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(10):1845-50.
2003: Clicerio González-Villalpando; David Rivera-Martínez; Martín Cisneros-Castólo; Ma Elena González-Villalpando; Jesús Simón; Ken Williams; Steven M Haffner; Michael P Stern
Seven-year incidence and progression of obesity. Characterization of body fat pattern evolution in low-income Mexico City urban population.
Archives of medical research 2003;34(4):348-53.
2003: Inmaculada Del Rincon; Ken Williams; Michael P Stern; Gregory L Freeman; Daniel H O'Leary; Agustin Escalante
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects.
Arthritis and rheumatism 2003;48(7):1833-40.
2003: Monica Nannipieri; Rosalinda Posadas-Sánchez; Ken Williams; Eudokia N Politi; C Gonzales-Villalpando; Michael P Stern; Ele Ferrannini
Association between polymorphisms of the atrial natriuretic peptide gene and proteinuria: a population-based study.
Diabetologia 2003;46(3):429-32.
2003: Anthony J G Hanley; Ken Williams; Clicerio Gonzalez; Ralph B D'Agostino; Lynne E Wagenknecht; Michael P Stern; Steven M Haffner
Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study.
Diabetes 2003;52(2):463-9.
2002: Thang S Han; Naveed Sattar; Ken Williams; Clicerio Gonzalez-Villalpando; Michael E J Lean; Steven M Haffner
Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.
Diabetes care 2002;25(11):2016-21.
2002: Michael P Stern; Pedram Fatehi; Ken Williams; Steven M Haffner
Predicting future cardiovascular disease: do we need the oral glucose tolerance test?
Diabetes care 2002;25(10):1851-6.
2002: Thang S Han; Ken Williams; Naveed Sattar; Kelly J Hunt; Michael E J Lean; Steven M Haffner
Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
Obesity research 2002;10(9):923-31.
2002: Kelly J Hunt; Ken Williams; Roy G Resendez; Helen Hazuda; Steven M Haffner; Michael P Stern
All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox".
Diabetes care 2002;25(9):1557-63.
2002: Steven M Haffner; Andrew S Greenberg; Wayde M Weston; Hongzi Chen; Ken Williams; Freed Martin
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Circulation 2002;106(6):679-84.
2002: Anthony J G Hanley; Ken Williams; Michael P Stern; Steven M Haffner
Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.
Diabetes care 2002;25(7):1177-84.
2002: Michael P Stern; Ken Williams; Steven M Haffner
Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?
Annals of internal medicine 2002;136(8):575-81.
2002: Rector Arya; John C Blangero; Ken Williams; Laura A Almasy; Thomas D Dyer; Robin J Leach; Peter O'Connell; Michael P Stern; Ravindranath Duggirala
Factors of insulin resistance syndrome--related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic mexican-americans.
Diabetes 2002;51(3):841-7.
2002: Carlos Lorenzo; Manuel Serrano-Rios; Maria T Martinez-Larrad; Rafael Gabriel; Ken Williams; Clicerio Gonzalez-Villalpando; Michael P Stern; Helen Hazuda; Steven M Haffner
Prevalence of hypertension in Hispanic and non-Hispanic white populations.
Hypertension 2002;39(2):203-8.
2002: Rector Arya; Ravindranath Duggirala; Laura A Almasy; David L Rainwater; Michael C Mahaney; Shelley Cole; Thomas D Dyer; Ken Williams; Robin J Leach; James E Hixson; Jean W MacCluer; Peter O'Connell; Michael P Stern; John C Blangero
Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans.
Nature genetics 2002;30(1):102-5.
2001: Inmaculada Del Rincon; Ken Williams; Michael P Stern; Gregory L Freeman; Agustin Escalante
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.
Arthritis and rheumatism 2001;44(12):2737-45.
2001: Carlos Lorenzo; Manuel Serrano-Rios; Maria T Martinez-Larrad; Rafael Gabriel; Ken Williams; Clicerio Gonzalez-Villalpando; Michael P Stern; Helen Hazuda; Steven M Haffner
Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study.
Diabetes care 2001;24(12):2059-64.
1999: James P Burke; Ken Williams; SP Gaskill; Helen Hazuda; Steven M Haffner; Michael P Stern
Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.
Archives of internal medicine 1999;159(13):1450-6.